Peptide therapy TikTok claims: what the science actually supports

What's this video probably claiming?

Based on the creator handle, category tagging, and the casual "get ready with me" format, this video almost certainly walks viewers through a peptide routine, likely framed around aesthetic or performance goals. Red hair is a physical identity marker that creators often tie to "biohacking" content, so the framing probably involves skin, hair quality, recovery, or body composition. The peptides most commonly featured in this format are GHK-Cu (for hair and skin), BPC-157 (injury recovery), and ipamorelin or CJC-1295 (growth hormone secretagogues). The tone is likely personal testimony mixed with surface-level mechanism claims, such as "this stimulates collagen" or "this fixes my gut," delivered while applying makeup or taking injections on camera. These videos generate high engagement precisely because they blend relatability with the appearance of medical authority. That combination is where misinformation risk concentrates.

What does the science actually show?

The honest answer is: it depends heavily on which peptide you're talking about, and the human data is thin across the board. GHK-Cu has legitimate peer-reviewed support for collagen synthesis stimulation in vitro and in wound-healing animal models. Pickart and Margolina (2018, Symmetry) documented its role in activating collagen and elastin genes, but human RCT data on systemic administration is essentially nonexistent. BPC-157 has shown consistent results in rat models for tendon, gut mucosal, and nerve repair, but as of 2024 there are zero completed phase II or phase III human clinical trials. Ipamorelin and CJC-1295 do stimulate pulsatile GH release, confirmed in small human studies like the Walker et al. (2021, Frontiers in Endocrinology) review, but the leap from "raises IGF-1" to "you'll look and feel better" is not supported by outcome data at the doses circulating on social media. MK-677, often lumped in as a peptide, is actually a small molecule with documented side effects including insulin resistance and edema at 25mg daily doses studied by Murphy et al. (1998, Journal of Clinical Endocrinology and Metabolism).

Where does the social media noise diverge from clinical reality?

The biggest divergence is the zero-risk framing. GRWM peptide content almost never mentions that most of these compounds are sold as research chemicals, not approved therapeutics, and that compounded versions vary significantly in purity and sterility. A 2022 FDA analysis found that a meaningful percentage of compounded peptide vials tested failed sterility or potency standards, which is a real clinical risk that gets no airtime. The second divergence is dose certainty. Creators often cite specific protocols with confidence that implies clinical validation. There is none for most of these compounds in humans. Third, and most significant for a platform like TikTok, is the immune modulation angle sometimes attached to Semax and Selank. Both are Russian-developed neuropeptides with animal data suggesting anxiolytic and nootropic effects, but the mechanism involves BDNF and serotonin pathways in ways that are poorly characterized in humans, meaning stacking them with SSRIs or other neurologically active substances carries real unknown risk that no GRWM video will flag.

What should you actually know?

Peptide therapy is a legitimate area of clinical interest, but the gap between what is studied and what is being self-administered based on TikTok content is significant. If you are considering any peptide protocol, the starting point should be a provider who can order baseline IGF-1, metabolic panels, and review your medication list, not a 60-second video. The FDA placed BPC-157, TB-500 (Thymosin Beta-4), and CJC-1295 on its list of bulk drug substances that cannot be compounded under section 503A and 503B as of 2023 guidance, which means sourcing these from telehealth platforms that are not operating within that regulatory framework carries legal and safety exposure. GHK-Cu in topical form remains available and has the strongest human-applicable safety profile of any peptide in this category. That distinction, topical versus injectable, versus oral, versus nasal, matters enormously for both safety and efficacy and is almost never addressed in creator content.